Eurobio Scientific SA (ALERS) — Cash Flow Quality Index
Eurobio Scientific SA (ALERS) has a Cash Flow Quality Index of 2.23x as of June 2025. Operating cash flow of €5.36 Million exceeds net income of €2.40 Million, indicating high earnings quality where cash backs reported profits. Explore ALERS strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Eurobio Scientific SA Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Eurobio Scientific SA across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Eurobio Scientific SA to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Eurobio Scientific SA (2019–2024)
Year-by-year earnings quality comparison for Eurobio Scientific SA. For live market cap and the full company financial profile, see Eurobio Scientific SA market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 4.18x | €16.70 Million | €4.00 Million | ▼ -24.5% |
| 2023 | 5.54x | €26.77 Million | €4.83 Million | ▲ +220.5% |
| 2022 | 1.73x | €43.07 Million | €24.94 Million | ▲ +58.7% |
| 2021 | 1.09x | €65.92 Million | €60.54 Million | ▲ +45.6% |
| 2020 | 0.75x | €54.93 Million | €73.48 Million | ▼ -52.8% |
| 2019 | 1.58x | €4.99 Million | €3.15 Million | — |